← All stocks

VERACYTE, INC.

VCYT Mostly scheduled
CIK 0001384101 #1647 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$22.16M
$10.09M on a plan · $11.62M straight out of an exercise
Sold at will
$449.91K
2 of 61 sales
Net
−$22.16M
−$449.91K against sales at will

By person

15 insiders · 61 transactions
25.2×

Marc Stapley holds 25.2 times base salary in stock. $17.69M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Marc Stapley last reported holding, valued at $40.95, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Stapley Marc
Chief Executive Officer
$8.92M (5) scheduled
−$8.92M
432,073
0.5375%
$17.69M
+34.7%
JONES EVAN/ FA
Director
$2.00M (7) scheduled
−$2.00M
34,634
0.0431%
$1.42M
−12.4%
Chambers Rebecca
Chief Financial Officer
$1.91M (9) scheduled
−$1.91M
166,025
0.2065%
$6.80M
+18.8%
McGuire Annie
EVP, General Counsel
$1.87M (15) scheduled
−$1.87M
131,160
0.1632%
$5.37M
+38.1%
Wygant Jonathan
VP, Chief Accounting Officer
$1.54M (3) scheduled
−$1.54M
43,226
0.0538%
$1.77M
−12.4%
EASTHAM KARIN
Director
$1.49M (6) scheduled
−$1.49M
15,097
0.0188%
$618.21K
−54.6%
Febbo Phillip G.
Chief Scientific & Med Officer
$1.35M (4) scheduled
−$1.35M
133,048
0.1655%
$5.45M
+42.9%
EPSTEIN ROBERT S
Director
$1.19M (2) scheduled
−$1.19M
57,718
0.0718%
$2.36M
+29.4%
Leite John
Global Chief Commercial Off
$1.17M (5) scheduled
−$1.17M
128,344
0.1597%
$5.26M
+68.5%
Holstein Jens
Director
$628.31K (4) scheduled
−$628.31K
27,471
0.0342%
$1.12M
−1.5%
Bhanji Muna
Director
$80.10K (1) scheduled
−$80.10K
42,718
0.0531%
$1.75M
+23.5%
Barr Eliav
Director
56,461
0.0702%
$2.31M
+34.9%
Haas Kevin Richard
Chief Dev and Tech Officer
44,221
0.0550%
$1.81M
Shafer David Brent
Director
31,100
0.0387%
$1.27M
+88.4%
Miller Thomas F.
Director
31,100
0.0387%
$1.27M
+88.4%
Insider
Date
Role
Action
Shares
Price
Amount
Holstein Jens
14 Sep 2026
Director
Sold on a plan
5,000
$40.95
$204.75K
McGuire Annie
4 Sep 2026
EVP, General Counsel
Sold on a plan
1,100
$43.67
$48.04K
McGuire Annie
4 Sep 2026
EVP, General Counsel
Sold on a plan
2,154
$42.79
$92.17K
Chambers Rebecca
4 Sep 2026
Chief Financial Officer
Sold on a plan
1,175
$43.71
$51.36K
Chambers Rebecca
4 Sep 2026
Chief Financial Officer
Sold on a plan
2,477
$42.81
$106.03K
Febbo Phillip G.
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
2,705
$43.66
$118.11K
Febbo Phillip G.
4 Sep 2026
Chief Scientific & Med Officer
Sold on a plan
10,405
$42.89
$446.30K
Bhanji Muna
1 Sep 2026
Director
Sold on a plan
1,864
$42.97
$80.10K
EASTHAM KARIN
18 Jun 2026
Director
Sold on a plan
529
$53.55
$28.33K
EASTHAM KARIN
18 Jun 2026
Director
Sold on a plan
3,200
$52.78
$168.91K
Leite John
4 Jun 2026
Global Chief Commercial Off
Sold on a plan
13,975
$50.07
$699.73K
Chambers Rebecca
4 Jun 2026
Chief Financial Officer
Sold on a plan
1,961
$50.09
$98.23K
Chambers Rebecca
4 Jun 2026
Chief Financial Officer
Sold on a plan
1,600
$49.28
$78.85K
McGuire Annie
4 Jun 2026
EVP, General Counsel
Sold on a plan
1,776
$50.12
$89.01K
McGuire Annie
4 Jun 2026
EVP, General Counsel
Sold on a plan
1,400
$49.31
$69.03K
EPSTEIN ROBERT S
20 May 2026
Director
Sold on a plan
10,000
$44.01
$440.13K
McGuire Annie
6 May 2026
SVP, General Counsel
Sold on a plan
5,102
$40.00
$204.08K
McGuire Annie
6 May 2026
SVP, General Counsel
Sold on a plan
5,102
$38.05
$194.13K
McGuire Annie
4 Mar 2026
SVP, General Counsel
Sold on a plan
1,664
$36.34
$60.47K
McGuire Annie
4 Mar 2026
SVP, General Counsel
Sold on a plan
4,994
$35.29
$176.26K
Leite John
4 Mar 2026
Chief Commercial Officer-CLIA
Sold on a plan
5,260
$35.19
$185.08K
Stapley Marc
4 Mar 2026
Chief Executive Officer
Sold on a plan
26,279
$36.28
$953.37K
Stapley Marc
4 Mar 2026
Chief Executive Officer
Sold on a plan
19,244
$35.56
$684.23K
Chambers Rebecca
4 Mar 2026
Chief Financial Officer
Sold on a plan
13,941
$36.33
$506.46K
Chambers Rebecca
4 Mar 2026
Chief Financial Officer
Sold on a plan
4,400
$35.55
$156.41K
Febbo Phillip G.
2 Mar 2026
Chief Scientific & Med Officer
Sold on a plan
13,425
$36.16
$485.43K
McGuire Annie
16 Dec 2025
SVP, General Counsel
Sold on a plan
100
$43.68
$4.37K
McGuire Annie
16 Dec 2025
SVP, General Counsel
Sold on a plan
10,639
$43.13
$458.84K
Leite John
4 Dec 2025
Chief Commercial Officer-CLIA
Sold on a plan
1,278
$47.51
$60.72K
Stapley Marc
4 Dec 2025
Chief Executive Officer
Sold on a plan
3,220
$47.35
$152.46K
Stapley Marc
4 Dec 2025
Chief Executive Officer
Sold on a plan
4,448
$46.90
$208.61K
Chambers Rebecca
4 Dec 2025
Chief Financial Officer
Sold on a plan
4,741
$47.25
$224.01K
Chambers Rebecca
4 Dec 2025
Chief Financial Officer
Sold on a plan
8,537
$46.61
$397.95K
McGuire Annie
4 Dec 2025
SVP, General Counsel
Sold on a plan
702
$47.51
$33.35K
McGuire Annie
4 Dec 2025
SVP, General Counsel
Sold on a plan
720
$47.10
$33.91K
JONES EVAN/ FA
25 Nov 2025
Director
Sold on a plan
1,106
$50.25
$55.58K
Leite John
25 Nov 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,808
$50.00
$140.40K
Holstein Jens
20 Nov 2025
Director
Sold on a plan
1,460
$43.21
$63.09K
Holstein Jens
20 Nov 2025
Director
Sold on a plan
7,049
$42.48
$299.42K
Holstein Jens
20 Nov 2025
Director
Sold on a plan
1,491
$40.95
$61.06K
Chambers Rebecca
5 Nov 2025
Chief Financial Officer
Sold on a plan
7,000
$41.00
$287.00K
EASTHAM KARIN
5 Nov 2025
Director
Sold on a plan
9,674
$40.02
$387.19K
McGuire Annie
5 Nov 2025
SVP, General Counsel
Sold on a plan
6,466
$40.00
$258.64K
Febbo Phillip G.
6 Oct 2025
Chief Scientific & Med Officer
Sold on a plan
8,349
$36.02
$300.71K
McGuire Annie
1 Oct 2025
SVP, General Counsel
Sold on a plan
2,160
$35.00
$75.61K
Leite John
1 Oct 2025
Chief Commercial Officer-CLIA
Sold on a plan
2,539
$35.00
$88.87K
McGuire Annie
19 Sep 2025
SVP, General Counsel
Sold on a plan
2,283
$33.69
$76.92K

What was left out

Form 4 filings counted 70
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 47
Sales straight out of an exercise 12
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 1,183,329
History held since 8 Dec 2016